Background: While substantial practice variation in coronary revascularization has been described and deviation from clinical practice guidelines has been associated with worse outcomes, the degree to which this is driven by flawed decision making and/or appropriate deviation associated with comorbid conditions is unknown. We evaluated heterogeneity in procedure use, and the extent to which hospital-level practice variation is related to surgical mortality.
A pproximately 1.35 million coronary revascularization procedures are performed annually in the United States, of which 71% are percutaneous coronary interventions (PCI) and 29% are coronary artery bypass grafting (CABG) surgeries. 1 While meta-analysis of 10 major cardiology trials 2 found comparable overall long-term mortality between the 2 procedures (with exception to elderly or diabetic patients, in whom CABG was associated with reduced mortality rates), the recent SYNTAX trial 3 found that anatomic complexity of coronary artery disease (CAD) was associated with varying treatment effects. Particularly, patients in the highest tertile of anatomic complexity (as represented by the SYNTAX score) had reduced mortality under CABG, although the extent to which disease anatomy was independently responsible for causing the observed differences in outcomes-particularly regarding comorbid conditions that covary with anatomic complexity-is unclear.
Practice guidelines for revascularization 4 reflect these findings, suggesting that both procedures are appropriate for multivessel CAD, although CABG is more appropriate among patients with certain types of complex 3-vessel CAD or CAD with left main stenosis. Yet, wide practice variation in revascularization therapy persists, 5, 6 and to date little is known as to why this is the case. One potential source of practice variation relates to decisions to proceed with major surgical revascularization among patients presenting with complex sets of comorbidities.
Preoperative evaluation is critical for informing surgical mortality risk under CABG. In practice, 2 risk models are commonly used: the EuroSCORE II 7 and the Society of Thoracic Surgeons (STS) score. 8 However, the consistency among providers and hospitals with which revascularization decisions are informed by these risk scores is unknown. Furthermore, both risk scores incorporate only a small amount of information on comorbid conditions, despite evidence that comorbidities are strongly associated with postoperative inhospital mortality. Validation studies [9] [10] [11] have produced C-statistics ranging from 0.71 to 0.84 for the EuroSCORE II and STS models, depending on the populations studied. These estimates suggest that, in the best case, the models account for 68% of overall rank-order discrimination for inhospital mortality, and in the worst case, only 42%. The remaining uncertainty is determined by either factors external to these models or by more complex relationships among factors internal to the models.
We have recently proposed a modeling methodology that yields measures of differential predicted risk among 2 (or more) treatments for a specific covariate profile. 12 In the current study, we applied this methodology to evaluate observed hospital-level variation in the use of PCI and CABG and its relationship with inhospital mortality after revascularization. Specifically, we compared risk-standardized mortality rates among hospitals in relation to a model that mapped distinct sets of comorbidities to predicted risk of mortality under both procedures. We hypothesized that hospitals with higher rates of discordance from the modelpreferred procedure (defined as the procedure that minimized predicted mortality risk) would have higher risk-adjusted mortality.
METHODS

Data Sources and Inclusion/Exclusion Criteria
We obtained administrative data on all hospital inpatient discharges occurring in 6 states (Arizona, California, Florida, Maryland, Michigan, and New Jersey) between 2009 and 2011 from the US Agency for Healthcare Research and Quality. We included discharges having either CABG (International Classification of Diseases, Ninth Revision, Clinical Modification, ICD-9-CM, procedure code of 36.1x) or PCI (ICD-9-CM procedure code of 36.09 or 00.66) as the principal procedure. CABG patients with stenting were classified into the CABG group. Hospitals with <100 total revascularizations over the 3-year time period were excluded.
Risk Modeling
Our risk modeling approach was centered on the creation of a decision rule that mapped patients' covariate values to a model-preferred revascularization treatment-either CABG or PCI-based on which procedure had the lower estimated probability of inhospital mortality. These estimated probabilities were based on procedure-specific logistic regression models (which were developed in a manner that ignored hospital assignment). We felt that the use of separate models for CABG and PCI more directly allowed the possibility of modeling fundamental differences between the 2 procedures in the nature of the relationship between co-variates and mortality. Details of this treatment effectiveness modeling approach are presented in Dalton et al. 12 The following variables were used as covariates in the logistic regression models: patient age and sex, state and year of discharge, type of admission (eg, emergency, transfer, etc.), patient locale (National Center for Health Statistics' Urban-Rural Code), and present-on-admission diagnoses (ICD-9-CM codes). As many diagnosis codes are sparsely represented, we aggregated certain diagnoses together by truncating trailing digits. Diagnoses were truncated (up to a minimum of 3 characters) if they were represented by <500 discharges. As a result of this aggregation routine, 746 distinct diagnosis-related covariates were created and considered for the models; 50.1% of diagnoses were not aggregated at all, 43.0% were truncated to 4 digits, 5.5% were truncated to 3 digits, and 1.4% did not meet minimal sample size requirements after aggregation and were thus mapped to an all-purpose "other diagnoses" covariate.
Age, sex, state, and year of discharge, type of admission, transfer status, and patient locale were forced into all risk models, whereas diagnosis-related covariates were selected using "elastic net" penalization. 13 As revascularization may have different risk profiles between men and women, [14] [15] [16] [17] [18] [19] we further considered sex-specific diagnosis effects by evaluating 2-way interactions. Issues involving computational complexity necessitated the use of a simplified routine to identify these interactions-specifically, we included an interaction between sex and a given diagnosis if, among patients with the diagnosis in question, there were at least 10 deaths for each sex and a univariate w 2 test for association in the sex-by-mortality contingency table was significant at the 0.05 level. Once all predictors and 2-way interactions with sex were selected, we refit the final models and estimated the probability of inhospital mortality for each discharges' specific covariate values, under each of the 2 treatments (regardless of which one was actually administered).
Discordance From the Model
Discharges were subsequently characterized as either concordant or discordant. Concordance was defined as occurring when the treatment actually received was the same as the model-preferred treatment (ie, the one with the lower estimated probability of inhospital mortality). Discordance was defined as occurring when patients received the opposite of the model-preferred treatment. Hospital discordance rates (HDRs) were then defined as the proportion of discordant discharges among all those treated at a given hospital. We clarify here that our use of the term "discordance" simply meant that the model-preferred treatment and actual treatment administered were not the same. It does not imply that physicians actively chose a treatment against information provided by the model.
HDRs were assessed for heterogeneity using both a histogram and a Bayesian binomial model. 20 The binomial distribution is a mixture distribution for binary outcomes characterized by multiple component binomial distributions, each with their own unique probability parameters; we thus modeled hospital-specific binomial distributions, each with their own HDR parameter. We used a noninformative Uni-form(0,1) prior probability distribution for the HDRs. Posterior estimates of mean and SD of the HDRs were then obtained from this model.
Relationship Between HDRs and Risk Standardized Mortality Ratios (RSMRs)
We implemented our primary analysis investigating the relationship between HDRs and risk-adjusted inhospital mortality using RSMRs. Although the objective of this analysis was to estimate associations between hospital-level characteristics and mortality-and not to report hospitalspecific quality measures-we followed the methodology for estimating RSMRs commissioned by the Committee of Presidents of Statistical Societies and funded by the Centers for Medicare and Medicaid Services, 21 with the exception that we used a frequentist hierarchical linear model instead of a Bayesian hierarchical linear model.
RSMRs were defined for each hospital as the number of observed deaths (during the 3 y study period) divided by the number of deaths predicted by our risk-adjustment model. Specifically, the expected number of deaths was defined (for each respective hospital) as the total number of predicted deaths (sum of individual patients' predicted probabilities) under the model-preferred treatment.
Hierarchical logistic regression models 22 were used to analyze the relationship between HDRs and hospital-level RSMRs. These models contained random intercepts to account for correlation among patients treated at the same hospital. An offset term, equal to each patient's predicted log odds of mortality under the preferred treatment (or actual treatment, in the case of the negative control analysis; see below), was included to directly model RSMRs. The following variables were included as fixed effects: HDR, source of admission, an indicator variable for whether or not the hospital performs CABG, hospital revascularization volume, and a propensity score defined as patients' estimated probability of receiving CABG given their age, sex, and aggregated (as described above under the "Risk Modeling" section) diagnoses. The slope for the HDR effect, and corresponding 95% confidence interval (CI) was then reported as a measure of the primary relationship of interest between hospital-level discordance from the risk model and hospital-level riskstandardized mortality. To evaluate potential nonlinearities, a separate model that incorporated restricted cubic splines for the HDR effect was visualized. Propensity scores were estimated using logistic regression.
Sensitivity Analyses
Changing the definition of expected mortality for a given hospital from the sum of patients' estimated probabilities under the model-preferred treatment to the sum of estimated probabilities under the actual treatment administered would impact the hospital's RSMR as the number of expected deaths would be greater. The reason for the relative increase in expected number of deaths is that, while estimated probabilities would not change for patients assigned the treatment that was in agreement with the model recommendation, estimated probabilities would be greater under the actual treatment given among patients assigned the opposite of the model-preferred treatment. (For example, if predicted mortality risk for a given group of 100 patients was 2% under PCI and 4% under CABG, and the patients all received PCI, then the expected number of deaths under the model-preferred treatment would be 2 under both the modelpreferred treatment and the actual treatment, which in this case would both be PCI. Had the 100 patients received CABG, however, then the expected number of deaths under the actual treatment would have been 4.)
Assuming our models accurately captured risk, using the number of expected deaths under the actual treatment administered would therefore effectively nullify the association between hospital-level discordance and RSMRs as the extra risk would be accounted for within the denominator. We evaluated this assumption in a negative control analysis wherein the primary association of interest (percent change in hospital-level RSMR associated with a relative HDR increment of 10%) was estimated using patients' estimated risk under actual treatment to define the expected number of deaths for each hospital. If, under this model, there was no association observed (in the presence of a positive association in the primary analysis), we would then conclude that observed associations were not artifacts due to erroneous risk estimation-at least with respect to the available covariates.
In a more detailed Monte Carlo sensitivity analysis (see Supplemental Digital Content 1, http://links.lww.com/ MLR/B151 under "Simulated Effects of Major Unobserved Confounding Variable"), we assessed the degree to which preferred treatment-and ultimately our results-might have been affected by an unavailable independent major confounding variable (eg, coronary lesion complexity).
Finally, in a third sensitivity analysis, we estimated the primary association of interest within certain restricted samples, to evaluate the extent to which our observed results may have been affected by inclusion of specific subpopulations. We excluded: (i) patients with ST-elevated myocardial infarctions (STEMIs, ICD-9-CM diagnosis code of 401.X, excluding 401.7), who tend to systematically receive PCI and have greater risk of mortality; (ii) transfer patients, whose risk profile may be systematically different from that of other sources of admission; (iii) CABG patients also undergoing secondary PCI, whose risk might not appropriately be captured by our models; and (iv) patients whose predicted risk was nearly equivocal between CABG and PCI (defined as predicted risk under CABG within ± 0.01 of predicted risk under PCI), effectively restricting the analysis to the subset of patients among whom discordance might most clearly be associated with higher risk of mortality.
hospitals ranged from 0% to 6.6%, with a median (first quartile, third quartile) of 1.3% (0.9%, 1.7%).
Our model for inhospital mortality after CABG included main effects for 266 diagnosis-related covariates (in addition to the demographic variables forced into the model), and 42 two-way interactions with sex (among those 266 covariates). Similarly, the model for mortality after PCI included 374 diagnosis-related covariates and 68 two-way interactions with sex. Discrimination and calibration of these models were good for each combination of sex and observed treatment (Fig. 2) ; C-statistics ranged between 0.84 (females) and 0.86 (males) for the CABG models and between 0.91 (females) and 0.93 (males) for the PCI models.
Overall, the risk model-based decision rule preferred CABG for 10% of discharges and PCI for the remaining 90%. The frequency of discordance with the model-preferred treatment was 27.8%; this frequency was 77.2% among discharges with CABG as the model-preferred treatment and was 22.3% among discharges with PCI as the model-preferred treatment. A summary of model-preferred treatments, discordance rates, and inhospital mortality among selected subpopulations is presented in Table 1 .
HDRs ranged from 3.6% to 59.0% among the 391 hospitals analyzed. On the basis of our Bayesian beta-binomial model, the HDRs had a mean (95% credibility interval) of 26.3% (25.3%-27.2%) and a SD of 9.6% (9.0%-10.4%). Hospitals with discordance rates >30% generally had greater volume, more elective transfers, fewer emergency cases, more patients from nonurban locales, were more likely to perform CABG, and had higher median propensity scores (estimated probability of receiving CABG given patients' covariates) than hospitals with discordance rates r20% ( Table 2) .
Propensity score distributions (estimated probability of receiving CABG, given information on patient characteristics and present-on-admission diagnoses, see Supplemental Digital Content, Fig. S-1 Our primary hierarchical linear model indicated a positive association between HDR and inhospital mortality after adjusting for source of admission, hospital-level use of CABG, volume, and propensity score, with a 10% increase in HDR associated with a 11% increase (95% CI, 5%-17% increase) in risk-standardized mortality (P < 0.001; Fig. 3 ). Comparing representative HDRs from the 2 tails of the observed distribution, hospitals with discordance rates of 40% had 37% (16%-60%) higher risk-standardized mortality than hospitals with discordance rates of 10%. On the basis of the dashed lines in Figure 3 -which represent pointwise 95% CI estimates for the displayed relationships under (respective) models that allowed for nonlinearities through restricted cubic splines-we concluded that the above linear characterization was justifiable.
In our negative control analysis, where we switched the definition of expected mortality from the number expected under the model-preferred treatment to the number expected under the actual treatment administered, this association was no longer significant [estimated slope for a 10% increase in HDR of À 1% (À 7% to +5%); P = 0.69], indicating that our models accurately captured risk with respect to the available covariates.
Effects of an unavailable independent covariate on the primary observed association were minimal despite large hypothetical prevalences and large hypothetical differential effects on mortality between PCI and CABG (see Supplemental Digital Content, Fig. S-2 , Supplemental Digital Content 1, http://links.lww.com/MLR/B151).
In the third sensitivity analysis, exclusion of neither discharges with STEMI [n = 108,191; 10% increase in HDR associated with a 21% (13%-30%) increase in hospital-level RSMR after removing these patients], transfer patients [n = 98,114; 11% (5%-18%)], CABG patients who had secondary PCI [n = 2351; 11% (5%-18%)], nor patients with equivocal predicted risk under PCI and CABG [n = 365,125 with predicted risk under CABG within ± 0.01 of predicted risk under PCI; 15% (9%-21%)] resulted in meaningful qualitative changes to the primary relationship of interest.
DISCUSSION
Model-based treatment recommendations can be desirable when their incorporation into shared decision-making practice leads to improved patient-centered outcomes. Here, we sought to use novel risk-based models as a platform to assess hospital-level variation in revascularization activities, independent of guidelines or appropriateness criteria. We found that discordance in the mode of revascularization in relation to our risk-based model's preferred treatment was strongly associated with increased risk-adjusted inhospital mortality. This suggests that, in aggregate, variation in preoperative evaluation practice in relation to patients' comorbidity profiles may be associated with worse outcomes and highlights the need to better understand its sources. Many possibilities exist. First, undesirable variation may be introduced as a result of sociodemographic characteristics. Hannan et al 23 found that African American and Hispanic patients were 35%-40% less likely to undergo CABG than similarly indicated and similarly insured white non-Hispanic patients. Female Medicare beneficiaries were observed to have a significantly lower risk-standardized chance of receiving CABG (27%) than their male counterparts (33%) and a significantly higher chance of receiving PCI (42% vs. 38%). 24 Finally, socioeconomic status has been associated with both access to 25 and outcomes after 26 CABG. In this study, females and African Americans received CABG less often despite comparable or even increased proportions that were recommended for CABG by the model. While we did not directly evaluate socioeconomic status, we note that the proportion of patients with private insurance who had model recommendations for CABG was lower than that among patients with other payers, despite comparable proportions actually receiving CABG.
Practice variation is also influenced by physician and practice-level factors, such as regret aversion, perceived low risk, avoidance of patient anxiety, and litigation risk. 27 Hospital-level variation may also be a function of logistical considerations including the preference of the referring physician, the onsite availability of cardiothoracic surgery, and economic incentives. Group-based decision-making processes like those of heart teams may reduce some forms of practice variation, but do not eliminate it altogether. For example, Bennett-Guerrero et al 28 identified enormous hospital-level variation in the use of erythrocyte transfusion among CABG patients. Furthermore, heart team-based processes may encourage an overly consistent approach to evaluating comorbidity risk within teams when variation in comorbidity risk may best be characterized by a complex predictive model. While clinical practice guidelines and appropriateness criteria can be used to inform decisionmaking tendencies, substantial knowledge gaps limit the applicability in many real-world settings, and limit their utility in the quantification of practice variation. Moreover, studies have suggested that physicians, like all humans, vary in their ability to accurately assess probabilities of events. [29] [30] [31] Our risk modeling framework used modern statistical algorithms to distinguish in-hospital mortality risk separately for both CABG and PCI using baseline covariates derived from a large, diverse, population-based registry. While this model did not account for anatomic factors such as atherosclerotic burden and lesion complexity-which are likely to heavily influence the decision for PCI versus CABG in practice-our models nonetheless explained between 68% and 86% of overall rank order discrimination for inhospital mortality among all 4 combinations of sex and procedure, with C-statistics ranging from 0.84 to 0.93. (We arrived at these figures through conversion of C-statistics to percent of rank-order discrimination explained, given by % explained = 2(C À 0.5).) This suggests that only modest amounts of residual discrimination (14%-32%) are left to be independently explained by unavailable factors such as complex anatomy, socioeconomic status, education, and preferences. Furthermore, our sensitivity analyses suggest that our observed relationship was robust to large and independent differential effects of a major unobserved covariate on inhospital mortality between PCI and CABG, and that removing the most appropriate subclass of patients indicated for PCI (namely, those with STEMI)-thereby restricting analysis to those for whom there is no clear consensus-actually strengthened the observed relationship.
Ideally, models similar to the one we use in this study might in the future provide meaningful guidance in complex clinical situations. However, this was not the purpose of the present study. Instead of defining optimal decision-making strategies per se, our efforts served as a means for uniform evaluation of hospital-level practice variation under observed decisions. Whether or not the current approach could serve as a "tool" for clinical decision support would need to be carefully and prospectively evaluated, in particular with respect to patient preferences, discount rates (especially the tradeoff between avoiding in-hospital mortality and maximizing chances of long-term survival), numeracy, and health literacy. Other key limitations inherent to this study also deserve to be highlighted. For instance, our analysis relies on coding of diagnoses, which can be inaccurate. 32, 33 Our use of administrative data limited the ability to identify patients who were ineligible for either procedure based on clinical factors. Finally, our analysis did not account for referral practice or readmissions, which represent important directions for future work; in particular, the reasons why hospitals without CABG capabilities had lower rates of discordance and their impact to the interpretation of the hospital-level performance measures need to be further studied.
In summary, the current study strongly suggests that a systematic approach to incorporating comorbidity as part of the decision-making process for coronary revascularization is needed. Our models, based largely on comorbid conditions, 
